SBK Pharma: what changed
What changed
SBK Pharma
NACE 64.210, Activities of holding companies
filed annual accounts (NBB)
Net result for the year
€8,967
2024 · €13,946-€4,979
Equity
€43,628
2024 · €34,661+€8,967
Cash
€1,063
2024 · €0+€1,063
Balance sheet total
€256,504
2024 · €254,400+€2,104
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
- Debts after one year -€29,026
down €29,026 (-30.0%), from €96,757 to €67,731
- Other debts +€26,275
up €26,275 (+31.1%), from €84,482 to €110,756
- Reserves +€8,967
up €8,967 (+31.3%), from €28,661 to €37,628
- Tax, wage and social debts -€3,548
down €3,548 (-100%), from €3,548 to €0
Income statement
- Gross operating margin -€6,266
down €6,266 (-30.3%), from €20,697 to €14,431
- Taxes -€1,358
down €1,358 (-34.9%), from €3,897 to €2,539
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€13,946
Gross operating margin
-€6,266
Other operating charges
-€0
Financial charges
-€71
Taxes
+€1,358
Result 2025
€8,967
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€29,446
Investment
€0
Financing
-€28,384
Cash 2024
€0
From operations (derived)
+€29,446
Net result for the year
+€8,967
Receivables within one year
-€2,105
Deferred charges and accrued income
+€1,064
Trade debts
-€1,432
Tax, wage and social debts
-€3,548
Other debts
+€26,275
Accrued charges and deferred income
+€225
Financing
-€28,384
Debts after one year
-€29,026
Current portion of long-term debt
+€642
Cash 2025
€1,063
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €254,400 | €256,504 | +€2,104 | +0.8% |
| Formation expenses | 20 | €0 | €0 | = | |
| Fixed assets | 21/28 | €251,775 | €251,775 | = | 0.0% |
| Financial fixed assets | 28 | €251,775 | €251,775 | = | 0.0% |
| Current assets | 29/58 | €2,626 | €4,729 | +€2,104 | +80.1% |
| Amounts receivable within one year | 40/41 | €1,561 | €3,666 | +€2,105 | +135% |
| Trade receivables | 40 | €0 | €0 | = | |
| Other amounts receivable | 41 | €1,561 | €3,666 | +€2,105 | +135% |
| Cash at bank and in hand | 54/58 | €0 | €1,063 | +€1,063 | |
| Deferred charges and accrued income | 490/1 | €1,064 | €0 | -€1,064 | -100% |
| Total equity and liabilities | 10/49 | €254,400 | €256,504 | +€2,104 | +0.8% |
| Equity | 10/15 | €34,661 | €43,628 | +€8,967 | +25.9% |
| Contributions | 10/11 | €6,000 | €6,000 | = | 0.0% |
| Reserves | 13 | €28,661 | €37,628 | +€8,967 | +31.3% |
| Distributable reserves | 133 | €28,661 | €37,628 | +€8,967 | +31.3% |
| Amounts payable | 17/49 | €219,739 | €212,876 | -€6,864 | -3.1% |
| Amounts payable after more than one year | 17 | €96,757 | €67,731 | -€29,026 | -30.0% |
| Financial debts | 170/4 | €96,757 | €67,731 | -€29,026 | -30.0% |
| Amounts payable within one year | 42/48 | €122,982 | €144,919 | +€21,937 | +17.8% |
| Current portion of amounts payable after more than one year | 42 | €28,384 | €29,026 | +€642 | +2.3% |
| Trade debts | 44 | €6,569 | €5,137 | -€1,432 | -21.8% |
| Suppliers | 440/4 | €6,569 | €5,137 | -€1,432 | -21.8% |
| Taxes, remuneration and social security | 45 | €3,548 | €0 | -€3,548 | -100% |
| Taxes | 450/3 | €3,548 | - | -€3,548 | |
| Other amounts payable | 47/48 | €84,482 | €110,756 | +€26,275 | +31.1% |
| Accrued charges and deferred income | 492/3 | - | €225 | +€225 | |
| Other operating charges | 640/8 | - | €0 | +€0 | |
| Gross operating margin | 9900 | €20,697 | €14,431 | -€6,266 | -30.3% |
| Operating profit (loss) | 9901 | €20,697 | €14,431 | -€6,266 | -30.3% |
| Financial charges | 65/66B | €2,854 | €2,925 | +€71 | +2.5% |
| Recurring financial charges | 65 | €2,854 | €2,925 | +€71 | +2.5% |
| Profit (loss) for the period before taxes | 9903 | €17,843 | €11,506 | -€6,337 | -35.5% |
| Income taxes | 67/77 | €3,897 | €2,539 | -€1,358 | -34.9% |
| Profit (loss) for the period | 9904 | €13,946 | €8,967 | -€4,979 | -35.7% |
| Profit (loss) for the period to be appropriated | 9905 | €13,946 | €8,967 | -€4,979 | -35.7% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.